0001181431-14-022240.txt : 20140623
0001181431-14-022240.hdr.sgml : 20140623
20140603134335
ACCESSION NUMBER: 0001181431-14-022240
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140529
FILED AS OF DATE: 20140603
DATE AS OF CHANGE: 20140603
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HARVARD BIOSCIENCE INC
CENTRAL INDEX KEY: 0001123494
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 043306140
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 84 OCTOBER HILL RD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
BUSINESS PHONE: 5088938999
MAIL ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HARTE NEAL J
CENTRAL INDEX KEY: 0001281069
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33957
FILM NUMBER: 14886785
4/A
1
rrd410888.xml
X0306
4/A
2014-05-29
2014-06-02
0
0001123494
HARVARD BIOSCIENCE INC
HBIO
0001281069
HARTE NEAL J
UNIT # 1
83 CHURCH STREET
WINCHESTER
MA
01890
1
0
0
0
Common Stock
2014-05-29
4
M
0
13317
3.82
A
37575
D
Common Stock
2014-05-29
4
S
0
12317
4.27
D
25258
D
Common Stock
2014-05-30
4
A
0
19400
0
A
44658
D
Stock option (right to buy)
3.82
2014-05-29
4
M
0
13317
0
D
2014-06-21
Common stock, par value $0.01 per share
13317
0
D
Represents shares sold to cover the exercise price of the option as part of a broker-assisted cashless exercise.
Includes a deferred stock award of 19,400 restricted stock units which shall fully vest on May 30, 2015.
Includes (a) a deferred stock award of 19,400 restricted stock units which shall fully vest on May 30, 2015; and (b) a deferred stock award of 3,688 restricted stock units which shall fully vest on June 1, 2015; and (c) 21,570 shares of common stock held by the Reporting Person.
The options vested in three equal installments on June 21, 2005, 2006 and 2007.
This transaction was executed in multiple trades at prices ranging from $4.2647 to $4.2721. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This form is filed to restate the initial Form 4 filing made on June 2, 2014 in order to correct the reported sale price regarding the shares sold to cover the exercise price of the reported option exercise as part of a broker-assisted cashless exercise. This form is signed under power of attorney.
Neal J. Harte
2014-06-03